Mutation in the ligand-binding domain of the retinoic acid receptor alpha in HL-60 leukemic cells resistant to retinoic acid and with increased sensitivity to vitamin D3 analogs

Leukemia Research

Volumn 20, Issue 9, 1996, Pages 761-769

  Doré, Benoit T ^a   Momparler, Richard L ^a  

^a UNIVERSITY OF MONTREAL   (Canada)

Author keywords

Point mutation; Retinoic acid receptor alpha; Retinoic acid resistance; Vitamin D3 analogs

Indexed keywords

9,10 SECOCHOLESTA 5,7,10(19),16 TETRAEN 23 YNE 1,3,25 TRIOL; ALITRETINOIN; ASPARTIC ACID; COLECALCIFEROL DERIVATIVE; GLYCINE; RETINOIC ACID; RETINOIC ACID RECEPTOR;

ACUTE MYELOBLASTIC LEUKEMIA; AMINO ACID SUBSTITUTION; ARTICLE; CELL STRAIN HL 60; CONTROLLED STUDY; DNA SEQUENCE; DRUG RESISTANCE; DRUG SENSITIVITY; HUMAN; HUMAN CELL; LEUKEMIA CELL; LIGAND BINDING; PRIORITY JOURNAL; PROTEIN DOMAIN;

EID: 0030250531     PISSN: 01452126     EISSN: None     Source Type: Journal    
DOI: 10.1016/0145-2126(96)00043-4     Document Type: Article

References (49)

1. 1. Huang M. E., Ye U. C., Chen S. R., Chai J. R., Lu J.X, Zhoa L., Gu L. J. & Wang Z. Y. (1988) Use of ati-trans retinoic acid in the treatment of acute promyelocytic leukemia. Blood 72, 567.
2. 2. Castaigne S., Chomienne C., Daniel M. T., Ballerini P., Berger R., Fenaux P. & Degos L. (1990) All-trans retinoic acid as a differentiation therapy for acute promyelocytic leukemia. I. Clinical results. Blood 76, 1704.
3. 3. Warrell R. P. Jr, Frankel S. R., Miller W. H. Jr, Scheinberg D. K., Itri L. M., Hittelman W. N., Vyas R., Andreeff M., Tafuri A., Jakubowski A., Gabrilove J., Gordon M. S. & Dmitrovsky E. (1991) Differentiation therapy of acute promyelocytic leukemia with tretinoin (all-trans-retinoic acid). N. Engl. J. Med. 24, 1385.
4. 4. Mangelsdorf D. J., Ong E. S., Dyck J. A. & Evans R. M. (1990) Nuclear receptor that identifies a novel retinoic acid response pathway. Nature 345, 224.
5. 5. Leid M., Kastner P., Lyons R., Nakshatri H., Saunders M., Zacharewski T., Chen J.-Y., Staub A., Garnier J.-M., Mader S. & Chambon P. (1992) Purification, cloning, and RXR identity of the HeLa cell factor with which RAR or TR heterodimerizes to bind target sequences efficiently. Cell 68, 377.
6. 6. Yu V. C., Delsert C., Andersen B., Holloway J. M., Devary O. V., Näär A. M., Kim S. Y., Boutin J.-M., Glass C. K. & Rosenfeld M. G. (1991) RXRβ: a coregulator that enhances binding of retinoic acid, thyroid hormone, and vitamin D receptor to their cognate response elements. Cell 67, 1251.
7. 3 signalling. Nature 355, 446.
8. 8. Warrell R. P. Jr. (1993) Retinoid resistance in acute promyelocytic leukemia: new mechanisms, strategies, and implications. Blood 82, 1949.
9. 9. Boylan J. F. & Gudas L. J. (1991) Overexpression of the cellular retinoic acid binding protein-I (CRABP-I) results in a reduction in differentiation-specific gene expression in F9 teratocarcinoma cells. J. Cell Biol. 112, 965.
10. 10. Cornic M., Delva L., Guidez F., Balitrand N., Degos L. & Chomienne C. (1992) Induction of retinoic acid-binding protein in normal and malignant human myeloid cells by retinoic acid in promyelocytic leukemia patients. Cancer Res. 52, 3329.
11. 11. Delva L., Cornic W., Balitrand N., Guidez F., Micléa J.-W., Delmer A., Teillet F., Fenaux P., Castaigne S., Degos L. & Chomienne C. (1993) Resistance to all-trans retinoic acid (ATRA) therapy in relapsing acute promyelocytic leukemia: study of in vitro ATRA sensitivity and cellular retinoic acid binding protein levels in leukemic cells. Blood 82, 2175.
12. 12. Muindi J., Frankel S. R., Miller W. H. Jr., Jakubowski K., Scheinberg D. A., Young C. W., Dmitrovsky E. & Warrel R. P. Jr. (1992) Continuous treatment with all-trans retinoic acid causes a progressive reduction in plasma drug concentrations: implications for relapse and retinoid "resistance" in patients with acute promyelocytic leukemia. Blood 79, 299.
13. 13. Muindi J. R. F., Frankel S. R., Huselton C., DeGrazia F., Garland W. A., Young C. W. & Warrel R. P. Jr. (1992) Clinical pharmacology of oral all-trans retinoic acid in patients with acute promyelocytic leukemia. Cancer Res. 52, 2138.
14. 14. Robertson K. A., Emami B. & Collins S. J. (1992) Retinoic acid-resistant HL-60R cells harbor a point mutation in the retinoic acid receptor ligand binding domain that confers dominant negative activity. Blood 80, 1885.
15. 15. Pratt M. A. C., Kralova J. & McBurney M. W. (1990) A dominant negative mutation of the alpha retinoic acid receptor gene in a retinoic acid-nonresponsive embryonal carcinoma cell. Mol. Cell Biol. 10, 6445.
16. 16. Robertson K. A., Emami B., Mueller L. & Collins S. J. (1992) Multiple members of the retinoic acid receptor family are capable of mediating the granulocytic differentiation of HL-60 cells. Molec. Cell Biol. 12, 3743.
17. 17. Sakashita A., Kazika M., Pakkala S., Schiller G., Tsuruoka N., Tomosaki R., Cameron J. F., Dawson M. I. & Koeffler H. P. (1993) 9-cis-Retinoic acid: effects on normal and leukemic hematopoiesis in vitro. Blood 81, 1009.
18. 18. Allenby G., Bocquel M. T., Saunders M., Kazmer S., Speck J., Rosenberger M., Lovey A., Kastner P., Grippo J. F., Chambon P. & Levin A. A. (1993) Retinoic acid receptors and retinoid X receptors: interactions with endogenous retinoic acids. Proc. natn. Acad. Sci. 90, 30.
19. 19. Brazzel R. F., Vane F. M., Ehmann C. W. & Colburn W. A. (1983) Pharmacokinetics of isotretinoin during repetitive dosing to patients. Eur. J. clin. Pharmacol. 24, 295.
20. 20. Mangelsdorf D. J., Borgmeyer U., Heyman R. A., Zhou J. Y., Ong E. S., Oro A. E., Kakizuka A. & Evans R. M. (1902) Characterization of three RXR genes that mediate the action of 9-cis retinoic acid. Genes Dev. 6, 329.
21. 21. Heyman R. A., Mangelsdorf D. J., Dyck J. A., Stein R. B., Eichele G., Evans R. M. & Thaller C. (1992) 9-Cis retinoic acid is a high affinity ligand for the retinoid X receptor. Cell 68, 397.
22. 22. Levin A. A., Sturzenbecker L. J., Kazmer S., Bosakowski T., Huselton C., Allenby G., Speck J., Kratzeisen C., Rosenberger M., Lovey A. & Grippo J. F. (1992) 9-Cis retinoic acid stereoisomer binds and activates the nuclear receptor RXR-α. Nature 355, 359.
23. 23. Mangelsdorf D. J., Umesono K, Kliewer S. A., Borgmeyer U., Ong E. S. & Evans R. M. (1991) A direct repeat in the cellular retinol-binding protein type II gene confers differential regulation by RXR and RAR. Cell 66, 555.
24. 3 analogs on HL-60 myeloid leukemic cells. Leukemia Res. 17, 749.
25. 3-26,23-lactone in inducing differentiation of human myeloid leukemia cells. Arch. Biochem. Biophys. 220, 90.
26. 3 and its fluorinated analogs. Cancer Res. 44, 5624.
27. 27. Binderup L. & Bramm E. (1988) Effects of a novel vitamin D analogue MC9O3 on cell proliferation and differentiation in vitro and on calcium metabolism in vivo. Biochem. Pharmac. 37, 889.
28. 28. Zhou J.-Y., Norman A. W., Lübbert M., Collins E. D., Uskokovic M. R. & Koeffler H. P. (1989) Novel vitamin D analogs that modulate leukemic cell growth and differentiation with little effect on either intestinal calcium absorption or bone calcium mobilization. Blood 74, 82.
29. 3: differential effects on leukemic cell growth, differentiation, and intestinal calcium absorption. Cancer Res. 50, 6857.
30. 30. Sato F., Okamoto Y., Ouchi Y., Kaneki M., Nakamura T., Ikekawa N. & Orimo H. (1991) Biological activity of 1α,25-dihydroxyvitamin D derivatives-24-epi-1α,25-dihydroxyvitamin D-2 and 1α,25-dihydroxyvitamin D-7. Biochim. biophys. Acta 1091, 188.
31. 3 analog with potent ability to induce HL-60 cell differentiation without modulating calcium metabolism. Blood 78, 75.
32. 32. Rebel V. I., Ossenkoppele G J., Van de Loosdrecht A. A., Wijemans P. W., Beelen R. H. J. & Langehuijsen M. M. A. C. (1992) Monocytic differentiation induction of HL-60 cells by MC9O3, a novel vitamin D analogue. Leukemia Res. 16, 443.
33. 3 prolongs survival time of leukemic mice. Proc. natn. Acad. Sci. 87, 3929.
34. 3 analog in HL-60 myeloid leukemic cells resistant to all-trans retinoic acid. Leukemia 8.
35. 35. Dimitriu-Bona A., Burmester G. R., Waters S. J. & Winchester R. J. (1983) Human mononuclear phagocyte differentiation antigens 1. Patterns of antigenic expression on the surface of human monocytes and macrophages defined by monoclonal antibodies. J. Immunol. 130, 145.
36. 36. Perussia B., Lebman D., Ip S. H., Rovera G. & Trinchieri G. (1981) Terminal differentiation surface antigens of myelomonocytic cells are expressed in human promyelocytic leukemia cells (HL-60) treated with chemical inducers. Blood 58, 836.
37. 37. Carlos T. M. & Harlan J. M. (1990) Membrane proteins involved in phagocyte adherence to endothelium. Immunol. Rev. 114, 5.
38. 38. Chomczynski P. & Sacchi N. (1987) Single-step method of RNA isolation by acid guanidinium thiocyanate-phenolchloroform extraction. Anal. Biochem. 162, 156.
39. 39. Giguère V., Ong E. S., Segui P. & Evans R. M. (1987) Identification of a receptor for the morphogen retinoic acid. Nature 330, 624.
40. 40. Petkovich M., Brand N. J., Krust A. & Chambon P. (1987) A human retinoic acid receptor which belongs to the family of nuclear receptors. Nature 330, 444.
41. 41. Collins S. J. (1988) Direct sequencing of amplified genomic fragments document N-ras point mutations in myeloid leukemia. Oncol. Res. 3, 117.
42. 42. Kretz K. A. & O'Brien J. S. (1993) Direct sequencing of polymerase chain reaction products from low melting temperature agarose. Meth. Enzymol. 218, 72.
43. 43. Jetten A. W., Grippo J. F. & Nervi C. (1990) Isolation and binding characteristics of nuclear retinoic acid receptors. Meth. Enzymol. 189, 248.
44. 44. Garner M. M. & Revzin A. (1981) A gel electrophoresis method for quantifying the binding of proteins to specific DNA regions: application to components of the Escherichia coli lactose operon regulatory system. Nucl. Acids Res. 9, 3047.
45. 45. Krieg P. A. & Melton D. A. (1984) Functional messenger RNAs are produced by SP6 in vitro transcription of cloned cDNAs. Nucl. Acids Res. 12, 7057.
46. 46. Wang A. M., Doyle M. V. & Mark D. F. (1989) Quantitation of mRNA by the polymerase chain reaction. Proc. natn. Acad. Sci. 86, 9717.
47. 47. Rosen E. D., Beninghof E. G. & Koenig R. J. (1993) Dimerization interfaces of thyroid hormone, retinoic acid, vitamin D, and retinoid X receptors. J. biol. Chem. 268, 11534.
48. 48. Dawson M. I., Elstner E., Kizaki M., Chen D. L., Pakkala S., Kerner B. & Koeffler H. P. (1994) Myeloid differentiation mediated through retinoic acid receptor/retinoic acid X receptor (RXR) not RXR/RXR pathway. Blood 84, 446.
49. 49. Schräder M., Bendik L., Becker-André M. & Carlberg C. (1993) Interaction between retinoic acid and vitamin D signaling pathways. J. Biol Biochem. 268, 17830.